Acne Vulgaris Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Acne Vulgaris Market
Acne Vulgaris Market: By Treatment (Adapalene, Tazaroteen, Tretinoin & Isotretinoin, Erythromycin & Clindamycin, Hormonal Agents, Anti-inflammatory, Azelaic acid, Resorcinol, Laser & Light Therapy, Cosmetic Procedures & Acne Scar Treatment); By Device (Laser & Heat Extraction devices); By Geography - Forecast(2018-2023)
Report Code : HCR 0108
Updated Date: 04 July, 2018  

1. Acne Vulgaris - Market Overview
2. Acne Vulgaris Market Executive Summary
3. Acne Vulgaris  Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Acne Vulgaris Market Forces
   4.1. Market Drivers 
   4.2. Market Constraints and Market Challenges
   4.3. Attractiveness of the Industry
      4.3.1. Power of Suppliers
      4.3.2. Power of Customers
      4.3.3. Threat of New entrants
      4.3.4. Threat of Substitution
      4.3.5. Degree of Competition
5. Acne Vulgaris Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2.   Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5.   Suppliers and Distributors
6. Acne Vulgaris Market – By Treatment
   6.1. Introduction
   6.2. Systemic Therapy
   6.3. Harmonal Therapy
      6.3.1. Oral Contraceptives
      6.3.2. Spironolactone
      6.3.3. Cyproterone Acetate
      6.3.4. Flutamide
   6.4. Topical Antibiotics
      6.4.1. Erythromycin
      6.4.2. Clindamycin
      6.4.3. Clarithromycin
      6.4.4. Azithromycin
      6.4.5. Nadifloxacin
   6.5. Topical Retinoids
      6.5.1. Adapalene
      6.5.2. Tazaroteen
      6.5.3. Tretinoin
      6.5.4. Isotretinoin
      6.5.5. Metretinide
      6.5.6. Retinaldehyde
      6.5.7. β-retinoyl glucuronide
   6.6. Physical Treatment
      6.6.1. Lesion Removal
            6.6.1.1. Comedones
            6.6.1.2. Active Deep Inflammatory Lesions
      6.6.2. Phototherapy
            6.6.2.1. Visible Light
            6.6.2.2. Photodynamic Therapy
   6.7. Benzoyl Peroxides
      6.7.1. Washes
      6.7.2. Cream
      6.7.3. Gel
   6.8. Topical Combination Therapy
      6.8.1. Benzoyl Peroxides + Antibiotics
      6.8.2. Retinoid + Benzoyl Peroxides
      6.8.3. Retinoid + Benzoyl Peroxides + Antibiotics
   6.9. Others
      6.9.1. Glycolic Acid Peels
      6.9.2. Salicylic Acid Peels
      6.9.3. Pulsed Dye Laser Treatments
7. Acne Vulgaris Market – By Geography
   7.1. North America 
      7.1.1. U.S.  
      7.1.2. Canada 
      7.1.3. Mexico 
      7.1.4. Rest of North America
   7.2. South America 
      7.2.1. Brazil 
      7.2.2. Venezuela
      7.2.3. Argentina
      7.2.4. Ecuador
      7.2.5. Peru
      7.2.6. Colombia 
      7.2.7. Costa Rica
      7.2.8. Rest of South America
   7.3. Europe 
      7.3.1. U.K 
      7.3.2. Germany 
      7.3.3. Italy 
      7.3.4. France
      7.3.5. Netherlands
      7.3.6. Belgium
      7.3.7. Spain
      7.3.8. Denmark
      7.3.9. Rest of Europe
   7.4. APAC
      7.4.1. China 
      7.4.2. Australia 
      7.4.3. South Korea
      7.4.4. India
      7.4.5. Taiwan
      7.4.6. Malaysia
      7.4.7. Hong Kong  
      7.4.7. Rest of APAC
   7.5. Middle East& Africa 
      7.5.1. Israel 
      7.5.2. South Africa
      7.5.3. Saudi Arabia
   7.6. Rest of Middle East and Africa
8. Acne Vulgaris Market Entropy
   8.1. New Product Launches
   8.2. M&As, Collaborations, JVs, Partnership
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Allergan
   9.2. Bayer AG
   9.3. Cipher
   9.4. Galderma S.A
   9.5. Hygeia Laboratories Inc
   9.6. Johnson & Johnson Private Limited
   9.7. Stiefel Laboratories
   9.8. Valeant Pharmaceutical International Inc.
   9.9. Novan Inc
   9.10. Vyome Bioscience
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll